|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 998 for Snca

0.027s
Type Details Score
Publication
First Author: Tomás-Zapico C
Year: 2012
Journal: Hum Mol Genet
Title: α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.
Volume: 21
Issue: 3
Pages: 495-510
Publication
First Author: Alvarez-Fischer D
Year: 2008
Journal: Exp Neurol
Title: Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Volume: 210
Issue: 1
Pages: 182-93
Publication
First Author: Beatman EL
Year: 2015
Journal: J Virol
Title: Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.
Volume: 90
Issue: 6
Pages: 2767-82
Publication
First Author: Luk KC
Year: 2012
Journal: Science
Title: Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.
Volume: 338
Issue: 6109
Pages: 949-53
Publication
First Author: Lim Y
Year: 2011
Journal: J Neurosci
Title: α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies.
Volume: 31
Issue: 27
Pages: 10076-87
Publication
First Author: Cabin DE
Year: 2002
Journal: J Neurosci
Title: Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein.
Volume: 22
Issue: 20
Pages: 8797-807
Publication
First Author: Watson JB
Year: 2009
Journal: Neuroscience
Title: Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein.
Volume: 159
Issue: 2
Pages: 501-13
Publication
First Author: Austin SA
Year: 2006
Journal: J Neurosci
Title: Alpha-synuclein expression modulates microglial activation phenotype.
Volume: 26
Issue: 41
Pages: 10558-63
Publication
First Author: Sarafian TA
Year: 2017
Journal: J Neurosci Res
Title: Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated α-synuclein.
Volume: 95
Issue: 9
Pages: 1871-1887
Publication
First Author: Sarafian TA
Year: 2013
Journal: PLoS One
Title: Impairment of mitochondria in adult mouse brain overexpressing predominantly full-length, N-terminally acetylated human α-synuclein.
Volume: 8
Issue: 5
Pages: e63557
Publication
First Author: Ellis CE
Year: 2005
Journal: Mol Cell Biol
Title: Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein.
Volume: 25
Issue: 22
Pages: 10190-201
Publication
First Author: Steidinger TU
Year: 2011
Journal: J Neurochem
Title: A neuroprotective role for angiogenin in models of Parkinson's disease.
Volume: 116
Issue: 3
Pages: 334-41
Publication
First Author: Golovko MY
Year: 2006
Journal: Biochemistry
Title: Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism.
Volume: 45
Issue: 22
Pages: 6956-66
Publication
First Author: Golovko MY
Year: 2005
Journal: Biochemistry
Title: Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding.
Volume: 44
Issue: 23
Pages: 8251-9
Publication
First Author: Rathke-Hartlieb S
Year: 2001
Journal: J Neurochem
Title: Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice.
Volume: 77
Issue: 4
Pages: 1181-4
Publication
First Author: Freichel C
Year: 2007
Journal: Neurobiol Aging
Title: Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice.
Volume: 28
Issue: 9
Pages: 1421-35
Publication
First Author: Neumann M
Year: 2002
Journal: J Clin Invest
Title: Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.
Volume: 110
Issue: 10
Pages: 1429-39
Publication
First Author: Schell H
Year: 2009
Journal: Neuroscience
Title: Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Volume: 160
Issue: 4
Pages: 796-804
Publication
First Author: Kahle PJ
Year: 2001
Journal: Am J Pathol
Title: Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.
Volume: 159
Issue: 6
Pages: 2215-25
Publication  
First Author: Paiva I
Year: 2018
Journal: Neurobiol Dis
Title: Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function.
Volume: 119
Pages: 121-135
Publication
First Author: Giasson BI
Year: 2002
Journal: Neuron
Title: Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.
Volume: 34
Issue: 4
Pages: 521-33
Publication
First Author: Sacino AN
Year: 2014
Journal: J Neurosci
Title: Brain injection of α-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker.
Volume: 34
Issue: 37
Pages: 12368-78
Publication
First Author: Choi SG
Year: 2024
Journal: Acta Neuropathol Commun
Title: Alpha-synuclein aggregates are phosphatase resistant.
Volume: 12
Issue: 1
Pages: 84
Publication  
First Author: Ayers JI
Year: 2018
Journal: J Virol
Title: Localized Induction of Wild-Type and Mutant Alpha-Synuclein Aggregation Reveals Propagation along Neuroanatomical Tracts.
Volume: 92
Issue: 18
Publication
First Author: Ferreira N
Year: 2021
Journal: Acta Neuropathol Commun
Title: Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain.
Volume: 9
Issue: 1
Pages: 31
Publication
First Author: Sacino AN
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice.
Volume: 111
Issue: 29
Pages: 10732-7
Publication
First Author: Wills J
Year: 2011
Journal: PLoS One
Title: Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.
Volume: 6
Issue: 3
Pages: e17953
Publication
First Author: Xie W
Year: 2012
Journal: J Neurochem
Title: Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease.
Volume: 122
Issue: 2
Pages: 404-14
Publication  
First Author: Wang W
Year: 2018
Journal: Neurochem Int
Title: Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
Volume: 114
Pages: 71-79
Publication  
First Author: Ma X
Year: 2021
Journal: Biomolecules
Title: Blood-Derived α-Synuclein Aggregated in the Substantia Nigra of Parabiotic Mice.
Volume: 11
Issue: 9
Publication
First Author: Oaks AW
Year: 2013
Journal: PLoS One
Title: Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function.
Volume: 8
Issue: 4
Pages: e60378
Publication
First Author: Woerman AL
Year: 2020
Journal: PLoS Pathog
Title: Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy.
Volume: 16
Issue: 2
Pages: e1008222
Publication
First Author: Farrell KF
Year: 2014
Journal: J Neurochem
Title: Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function.
Volume: 128
Issue: 4
Pages: 536-46
Publication
First Author: Nemani VM
Year: 2010
Journal: Neuron
Title: Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.
Volume: 65
Issue: 1
Pages: 66-79
Publication
First Author: Matsuoka Y
Year: 2001
Journal: Neurobiol Dis
Title: Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.
Volume: 8
Issue: 3
Pages: 535-9
Publication
First Author: Masliah E
Year: 2000
Journal: Science
Title: Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.
Volume: 287
Issue: 5456
Pages: 1265-9
Publication
First Author: Lee HJ
Year: 2010
Journal: J Biol Chem
Title: Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies.
Volume: 285
Issue: 12
Pages: 9262-72
Publication
First Author: Bender A
Year: 2013
Journal: PLoS One
Title: TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease.
Volume: 8
Issue: 4
Pages: e62277
Publication
First Author: Richfield EK
Year: 2002
Journal: Exp Neurol
Title: Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
Volume: 175
Issue: 1
Pages: 35-48
Publication  
First Author: Keomanivong C
Year: 2024
Journal: eNeuro
Title: Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits.
Volume: 11
Issue: 2
Publication
First Author: McFleder RL
Year: 2023
Journal: Nat Commun
Title: Brain-to-gut trafficking of alpha-synuclein by CD11c(+) cells in a mouse model of Parkinson's disease.
Volume: 14
Issue: 1
Pages: 7529
Publication
First Author: Liu CW
Year: 2005
Journal: J Biol Chem
Title: A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.
Volume: 280
Issue: 24
Pages: 22670-8
Publication
First Author: Li W
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations.
Volume: 102
Issue: 6
Pages: 2162-7
Publication
First Author: Teravskis PJ
Year: 2018
Journal: J Neurosci
Title: A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
Volume: 38
Issue: 45
Pages: 9754-9767
Publication
First Author: Stefanova N
Year: 2005
Journal: Am J Pathol
Title: Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.
Volume: 166
Issue: 3
Pages: 869-76
Publication
First Author: Sumitomo A
Year: 2018
Journal: Sci Adv
Title: A mouse model of 22q11.2 deletions: Molecular and behavioral signatures of Parkinson's disease and schizophrenia.
Volume: 4
Issue: 8
Pages: eaar6637
Publication
First Author: Kulkarni VV
Year: 2022
Journal: J Neurosci
Title: Retrograde Axonal Autophagy and Endocytic Pathways Are Parallel and Separate in Neurons.
Volume: 42
Issue: 45
Pages: 8524-8541
Publication
First Author: Lu XH
Year: 2009
Journal: J Neurosci
Title: Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
Volume: 29
Issue: 7
Pages: 1962-76
Publication
First Author: Henderson MX
Year: 2019
Journal: Nat Neurosci
Title: Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis.
Volume: 22
Issue: 8
Pages: 1248-1257
Publication  
First Author: Trubetckaia O
Year: 2019
Journal: Commun Biol
Title: Alpha-synuclein is strategically positioned for afferent modulation of midbrain dopamine neurons and is essential for cocaine preference.
Volume: 2
Pages: 418
Publication      
First Author: Matsuo K
Year: 2024
Journal: Cell
Title: RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation.
Publication  
First Author: Abdelmotilib H
Year: 2017
Journal: Neurobiol Dis
Title: α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration.
Volume: 105
Pages: 84-98
Publication
First Author: Fonseca-Ornelas L
Year: 2021
Journal: Cell Rep
Title: Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson's disease.
Volume: 36
Issue: 1
Pages: 109333
Publication  
First Author: Kim T
Year: 2018
Journal: Sci Signal
Title: The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein.
Volume: 11
Issue: 560
Publication
First Author: Nuber S
Year: 2018
Journal: Neuron
Title: Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease.
Volume: 100
Issue: 1
Pages: 75-90.e5
Publication
First Author: Games D
Year: 2014
Journal: J Neurosci
Title: Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models.
Volume: 34
Issue: 28
Pages: 9441-54
Publication
First Author: Schreglmann SR
Year: 2015
Journal: PLoS One
Title: The temporal expression pattern of alpha-synuclein modulates olfactory neurogenesis in transgenic mice.
Volume: 10
Issue: 5
Pages: e0126261
Publication
First Author: Yan R
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
Volume: 115
Issue: 51
Pages: E12053-E12062
Publication  
First Author: Savolainen MH
Year: 2014
Journal: Neurobiol Dis
Title: The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.
Volume: 68
Pages: 1-15
Publication  
First Author: Hansen C
Year: 2013
Journal: Neurobiol Dis
Title: A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
Volume: 56
Pages: 145-55
Publication
First Author: Yazawa I
Year: 2005
Journal: Neuron
Title: Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.
Volume: 45
Issue: 6
Pages: 847-59
Publication
First Author: Rieker C
Year: 2011
Journal: PLoS One
Title: Neuropathology in mice expressing mouse alpha-synuclein.
Volume: 6
Issue: 9
Pages: e24834
Publication
First Author: Shults CW
Year: 2005
Journal: J Neurosci
Title: Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
Volume: 25
Issue: 46
Pages: 10689-99
Publication
First Author: Rockenstein E
Year: 2005
Journal: J Neurosci Res
Title: Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein.
Volume: 80
Issue: 2
Pages: 247-59
Publication
First Author: Nuber S
Year: 2021
Journal: Ann Neurol
Title: A Stearoyl-Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α-Synuclein Mice.
Volume: 89
Issue: 1
Pages: 74-90
Publication
First Author: Geertsma HM
Year: 2022
Journal: Hum Mol Genet
Title: Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregation.
Volume: 31
Issue: 21
Pages: 3613-3628
Publication
First Author: Rochet JC
Year: 2000
Journal: Biochemistry
Title: Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein.
Volume: 39
Issue: 35
Pages: 10619-26
Publication
First Author: Nakai M
Year: 2007
Journal: Biochem Biophys Res Commun
Title: Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage.
Volume: 358
Issue: 1
Pages: 104-10
Publication
First Author: Doxakis E
Year: 2010
Journal: J Biol Chem
Title: Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153.
Volume: 285
Issue: 17
Pages: 12726-34
Publication
First Author: Kontopoulos E
Year: 2006
Journal: Hum Mol Genet
Title: Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.
Volume: 15
Issue: 20
Pages: 3012-23
Publication
First Author: Esposito G
Year: 2012
Journal: Dev Neurobiol
Title: Synaptic vesicle trafficking and Parkinson's disease.
Volume: 72
Issue: 1
Pages: 134-44
Publication
First Author: Qureshi HY
Year: 2011
Journal: J Biol Chem
Title: Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro.
Volume: 286
Issue: 7
Pages: 5055-68
Publication
First Author: Volles MJ
Year: 2007
Journal: J Mol Biol
Title: Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity.
Volume: 366
Issue: 5
Pages: 1510-22
Publication
First Author: Sommer B
Year: 2000
Journal: Exp Gerontol
Title: Mouse models of alpha-synucleinopathy and Lewy pathology.
Volume: 35
Issue: 9-10
Pages: 1389-403
Publication
First Author: Dawson TM
Year: 2000
Journal: Cell
Title: New animal models for Parkinson's disease.
Volume: 101
Issue: 2
Pages: 115-8
Publication
First Author: Dawson VL
Year: 2000
Journal: Science
Title: Neurobiology. Of flies and mice.
Volume: 288
Issue: 5466
Pages: 631-2
Publication
First Author: Yavich L
Year: 2005
Journal: Neurobiol Dis
Title: Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein.
Volume: 20
Issue: 2
Pages: 303-13
Publication
First Author: Siegmund A
Year: 2005
Journal: Behav Brain Res
Title: Differences in extinction of conditioned fear in C57BL/6 substrains are unrelated to expression of alpha-synuclein.
Volume: 157
Issue: 2
Pages: 291-8
Publication
First Author: Larsen KE
Year: 2006
Journal: J Neurosci
Title: Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis.
Volume: 26
Issue: 46
Pages: 11915-22
Publication
First Author: Martinez-Vicente M
Year: 2008
Journal: J Clin Invest
Title: Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.
Volume: 118
Issue: 2
Pages: 777-88
Publication
First Author: Nakayama K
Year: 2009
Journal: Am J Pathol
Title: Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy.
Volume: 174
Issue: 4
Pages: 1471-80
Publication  
First Author: Ikeda M
Year: 2009
Journal: Brain Res
Title: Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology.
Volume: 1250
Pages: 232-41
Publication
First Author: Unni VK
Year: 2010
Journal: PLoS One
Title: In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility.
Volume: 5
Issue: 5
Pages: e10589
Publication  
First Author: Kim YH
Year: 2011
Journal: Neuroscience
Title: Inducible dopaminergic glutathione depletion in an α-synuclein transgenic mouse model results in age-related olfactory dysfunction.
Volume: 172
Pages: 379-86
Publication
First Author: Feng LR
Year: 2010
Journal: Eur J Neurosci
Title: Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability.
Volume: 32
Issue: 1
Pages: 10-7
Publication
First Author: Volpicelli-Daley LA
Year: 2011
Journal: Neuron
Title: Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.
Volume: 72
Issue: 1
Pages: 57-71
Publication
First Author: Park SN
Year: 2011
Journal: Neurosci Res
Title: α-Synuclein deficiency and efferent nerve degeneration in the mouse cochlea: a possible cause of early-onset presbycusis.
Volume: 71
Issue: 3
Pages: 303-10
Publication  
First Author: Huang Z
Year: 2011
Journal: Neuroscience
Title: Determining nuclear localization of alpha-synuclein in mouse brains.
Volume: 199
Pages: 318-32
Publication
First Author: Burré J
Year: 2012
Journal: J Neurosci
Title: Systematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activities.
Volume: 32
Issue: 43
Pages: 15227-42
Publication
First Author: Guardia-Laguarta C
Year: 2014
Journal: J Neurosci
Title: α-Synuclein is localized to mitochondria-associated ER membranes.
Volume: 34
Issue: 1
Pages: 249-59
Publication
First Author: Gardai SJ
Year: 2013
Journal: PLoS One
Title: Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.
Volume: 8
Issue: 8
Pages: e71634
Publication
First Author: Reyes JF
Year: 2014
Journal: Glia
Title: Alpha-synuclein transfers from neurons to oligodendrocytes.
Volume: 62
Issue: 3
Pages: 387-98
Publication
First Author: Aelvoet SA
Year: 2014
Journal: J Neurosci
Title: Noninvasive bioluminescence imaging of α-synuclein oligomerization in mouse brain using split firefly luciferase reporters.
Volume: 34
Issue: 49
Pages: 16518-32
Publication  
First Author: Dettmer U
Year: 2015
Journal: Nat Commun
Title: Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation.
Volume: 6
Pages: 7314
Publication  
First Author: Tank J
Year: 2014
Journal: Physiol Rep
Title: Preserved functional autonomic phenotype in adult mice overexpressing moderate levels of human alpha-synuclein in oligodendrocytes.
Volume: 2
Issue: 11
Publication
First Author: Pinho R
Year: 2019
Journal: Hum Mol Genet
Title: Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein.
Volume: 28
Issue: 1
Pages: 31-50
Publication
First Author: Schaser AJ
Year: 2019
Journal: Sci Rep
Title: Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders.
Volume: 9
Issue: 1
Pages: 10919
Publication
First Author: Yan DY
Year: 2019
Journal: Neurotox Res
Title: Mn-Induced Neurocytes Injury and Autophagy Dysfunction in Alpha-Synuclein Wild-Type and Knock-Out Mice: Highlighting the Role of Alpha-Synuclein.
Volume: 36
Issue: 1
Pages: 66-80
Publication  
First Author: Parajuli LK
Year: 2020
Journal: eNeuro
Title: Developmental Changes in Dendritic Spine Morphology in the Striatum and Their Alteration in an A53T α-Synuclein Transgenic Mouse Model of Parkinson's Disease.
Volume: 7
Issue: 4
Publication  
First Author: Li H
Year: 2021
Journal: Front Neurosci
Title: Dl-3-n-Butylphthalide Alleviates Behavioral and Cognitive Symptoms Via Modulating Mitochondrial Dynamics in the A53T-α-Synuclein Mouse Model of Parkinson's Disease.
Volume: 15
Pages: 647266